logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 700 Anti-human CD9 Antibody
HI9a
HI9a is an anti-human monoclonal antibody that recognizes the CD9 antigen. CD9 (alternatively called MIC3, TSPAN29, Tetraspanin or 5H9 antigen) is a 24 kD member of the Tetraspan family that is expressed on the surface of cells like macrophages, granulocytes, epithelial cells, platelets and endothelial cells. In many organisms, CD9 is involved in the negative regulation of cellular component movement, represses cell population proliferation and negatively regulates platelet aggregation. From a research standpoint, it is of biological interest due to its association with critical macromolecules/ligands such as Integrin β1. CD9 is a fairly uncommon antibody target, with a little more than 6100 publications in the last decade. Even still, CD9 is frequently used in flow cytometry applications as a phenotypic marker for differentiation of cell types, particularly in the study of immunology and stem cells. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 700 (ex/em = 566/708 nm). It is compatible with the 561 nm laser and 710/50 nm bandpass filter (for example, as in the BD FACSAria™ III).
product image
product image
CatalogSize
Price
Quantity
100901X025 tests
Price
100901X1100 tests
Price
100901X2500 tests
Price
 
Antibody properties

Other namesMRP-1; P24
CloneHI9a
Hostmouse
Isotypemouse IgG1
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)708
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 9, 2025